Penn Medicine Partners with Cost Plus to Combat Drug Costs and Shortages

Penn Medicine has partnered with Mark Cuban's Cost Plus Drug Company to combat rising medication prices and ongoing drug shortages by purchasing the 100 most frequently dispensed medications from the Cost Plus Marketplace. This initiative, intended to provide more affordable access to essential drugs, comes as Penn Medicine operates 16 retail pharmacies that fill over 1.5 million prescriptions annually. The collaboration represents the third alliance formed with Cost Plus Drugs, joining ScionHealth and Community Health Systems. The Cost Plus Marketplace aims to enhance the availability of medications while CEO Kevin Mahoney noted that savings from eliminating generic medication mark-ups will be reinvested into innovative care solutions, though immediate cost reductions for patients may not be realized at the pharmacy level.

Opens on Becker's Hospital Review